Skyscape Web Viewer : Radiation Oncology Question Review : Main Index

View All
About
Adjuvant Navelbine International Trialist Association (ANITA) trial
Altered fractionation
Amifostine Answer 1.12 Question 1.12
Anal cancer
Anaplastic gliomas 1p19q deletion, impact of anaplastic oligodendrogliomas bromodeoxyuridine (BUdR) therapy chemotherapy incidence rate radiation therapy for temozolomide in treatment for
ANITA trial
Arteriovenous malformation implications for not treating risk of hemorrhage following radiosurgery Spetzler-martin grading scheme stereotactic radiosurgery (SRS) toxicities associated with SRS
Bevacizumab Answer 2.101 Question 2.101
Bilateral diagnostic mammogram Question 3.25 Question 3.26
Biliary tract malignancy
Bladder cancer adenocarcinoma of, site for bladder preservation treatment chemoRT, OS for chemotherapy to definitive radiation cisplatinum-based chemoradiation contraindications with chemoradiation neoadjuvant chemotherapy patients outcomes with TN staging transitional cell carcinoma of, site for treatment planning with radiation
Brachytherapy Answer 7.114 Answer 7.115 GEC-eSTRO dose guidelines ICRU Report LDR vs HDR Question 7.115
Brain metastases
Brainstem gliomas in children and adolescents chemotherapy hyperfractionation incidence rate prognostic factors radiation therapy
Breast cancer
bromodeoxyuridine (BUdR) therapy
Cardiac tumors adjuvant radiation therapy common management median survival rate primary pericardial tumor toxicities with irradiation therapy
Cervical cancer
Cetuximab dose
Chemoradiation Answer 1.12_2 Question 1.12_2
CHOD chemotheraphy
Cholangiocarcinoma higher risk factor for recurrence histologic variant incidence rate mayo clinic liver transplant selection criteria and protocol radiation therapy for resectability of risk factors for role for SBRT in signs and symptoms
CNS radiation toxicities/therapies for toxicities bevacizumab Cahan's criteria for radiation-induced neoplasm classification of radiation injury donepezil following radiation of spinal cord methylphenidate phenytoin risk of optic neuropathy
Craniopharyngioma cyst management endocrine abnormalities histologies incidence rate long-term outcomes of primary management prognostic features radiation therapy radiosurgery (SRS) resection of survival rates
craniospinal irradiation (CSI)
CSI
cyclophosphamide, doxorubicin, vincristine, and dexamethasone (CHOD) chemotherapy Answer 2.69 Question 2.69
Donepezil Answer 2.100 Question 2.100
Early Lung Cancer Action Project (ELCAP)